Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001778981-19-000003
Filing Date
2019-07-30
Accepted
2019-07-30 17:40:59
Documents
1
Period of Report
2019-07-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3864
  Complete submission text file 0001778981-19-000003.txt   5301
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
MacDonald Sean Arthur (Reporting) CIK: 0001778981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 19986619